Products and Applications Proliferate in the Growing Market for Surgical Sealants, Glues and Wound Closure, According to New Report from MedMarket Diligence, LLC
Clinical experience with sealants, hemostatic agents, glues and a variety of novel wound closure technologies is coinciding with increased caseload in many different specialties including orthopedic, cardiovascular, dermal, surgical, neurology, and others. These multiple opportunities are driving an $11 billion market by 2014.
(PRWEB) January 21, 2005 -- The market potential for products in the surgical
securement field is driven by a combination of new technologies coming to market
and expanding application caseloads. The potential for these products will grow
steadily over the coming decade as surgical practices improve and the benefits
of new products address the requirement for fast and effective
closure.
MedMarket Diligence forecasts that approximately 70 million
procedures around the world might benefit from sealants, glues, and other wound
closure products in this group. Select products and applications will grow at
rates near 20% annually.
In the next few years, we will see strong
penetration of new therapies into new procedure areas, and some new introductory
techniques for treatment of orthopedic, cardiovascular and neurological
procedures, particularly in the second half of this decade, when several new
products and procedures will appear in all of these categories.
A number
of market leaders have consolidated their positions within the surgical closure
and securement markets through successful internal development programs and
through technology partnerships with innovative vendors of next generation
technologies. For example, U.S. Surgical and Ethicon are major suppliers of
cyanoacrylate products in the USA; with dominant sales resource to sell these
products these companies lead the market, although they will face competition
from the Canadian company Glustitch, the UK-based MedLogic and others. Synovis
has targeted cardiovascular and other procedures, and has a range of closure
products and has recently partnered with GEM to develop and exploit GEM’s
internal high strength glue product (Glubran) in the USA.
The market
remains replete with competitors, including Focal (Genzyme Biosurgery),
Angiotech BioMaterials (Cohesion Technologies), Fusion Medical, Confluent
Surgical, CryoLife, Medchem (C.R. Bard), Tissuemed, Surgical Sealants,
Ethicon/Closure Medical, U.S. Surgical (Tyco Group), Haemacure, MedLogic Global
(Advanced Medical Solutions), GEM srl, Chemence, Glustitch, Berlin Heart, and
many others.
The "Worldwide Surgical Sealants, Glues and Wound Closure
Market, 2004-2014" report, published January 2005, covers sealants, glues,
tapes, sutures, staples, hemostats, fibrin sealants/glues, and medical
adhesives. The report details the clinical and technology developments
underlying growth and opportunity in the market, detailing products on the
market and under development, with detail on market size and forecast,
competitor market shares, competitor profiles and market opportunity. Details of
the report, including table of contents and list of exhibits, are available at
http://www.mediligence.com/rpt-s122.htm.
MedMarket
Diligence provides tactical decision-making solutions on medical technology to
the medical products and investment industries. The company publishes the
“MedMarkets” newsletter, a monthly analysis of the market implications of new
medical technology and dedicated reports on technology markets. For more
information on MedMarket Diligence, LLC, contact Patrick Driscoll at (949)
859-3401, email (http://www.mediligence.com/contact_us.htm) or visit http://www.mediligence.com.
# # #
Source : http://www.prweb.com/releases/2005/1/prweb200159.htm